Phosphorothioate-modified CpG oligodeoxynucleotides mimic autoantigens and reveal a potential role for Toll-like receptor 9 in receptor revision

被引:7
|
作者
Doster, Anne [1 ]
Ziegler, Saskia [1 ]
Foermer, Sandra [1 ]
Rieker, Ralf Joachim [2 ,3 ]
Heeg, Klaus [1 ]
Bekeredjian-Ding, Isabelle [1 ,4 ]
机构
[1] Univ Heidelberg Hosp, Dept Infect Dis Med Microbiol & Hyg, Heidelberg, Germany
[2] Univ Heidelberg Hosp, Dept Pathol, Heidelberg, Germany
[3] Univ Hosp Erlangen, Inst Pathol, Erlangen, Germany
[4] Univ Hosp Bonn, IMMIP, D-53105 Bonn, Germany
关键词
autoimmunity; B-cell receptor; B cells; CpG DNA; Toll receptors; Toll-like receptors; SYSTEMIC-LUPUS-ERYTHEMATOSUS; B-CELL RECEPTOR; RECOMBINATION-ACTIVATING GENES; PLASMACYTOID DENDRITIC CELLS; RAG EXPRESSION; PERIPHERAL-BLOOD; V(D)J RECOMBINATION; INDUCTION; REEXPRESSION; LYMPHOCYTES;
D O I
10.1111/imm.12063
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Re-expression of recombinase activating genes (RAG) in mature B cells may support autoreactivity by enabling revision of the B-cell receptor (BCR). Recent reports suggest that administration of Toll-like receptor 9 (TLR9) -stimulating CpG oligodeoxynucleotides (ODN) could trigger the manifestation of autoimmune disease and that TLR are involved in the selection processes eliminating autoreactive BCR. The mechanisms involved remain to be elucidated. This prompted us to ask, whether TLR9 could be involved in receptor revision. We found that phosphorothioate-modified CpG ODN (CpGPTO) induced expression of Ku70 and re-expression of RAG-1 in human peripheral blood B lymphocytes and Ig expression in sorted Ig+ B cells. Further results revealed unselective binding specificity of CpGPTO-induced immunoglobulin and suggested that CpGPTO engage and/or mimic IgM receptor signalling, an important prerequisite for the initialization of receptor editing or revision. Altogether, our data describe a potential role for TLR9 in receptor revision and suggest that CpGPTO could mimic chromatin-bearing autoantigens by simultaneously engaging the BCR and TLR9 on IgM+ B cells.
引用
收藏
页码:166 / 178
页数:13
相关论文
共 50 条
  • [1] Role of toll-like receptor 9 in immune-adrenal response to CPG oligodeoxynucleotides
    Zacharowski, Kai
    Tran, Nguyen
    Koch, Alex
    Zacharowski, Paula
    Lightmann, Stafford
    INFLAMMATION RESEARCH, 2007, 56 : S117 - S117
  • [2] Toll-Like Receptor 9 Activation with CpG Oligodeoxynucleotides for Asthma Therapy
    Kline, Joel N.
    Krieg, Arthur M.
    DRUG NEWS & PERSPECTIVES, 2008, 21 (08) : 434 - 439
  • [3] Antitumor applications of stimulating Toll-like receptor 9 with CpG oligodeoxynucleotides
    Krieg A.M.
    Current Oncology Reports, 2004, 6 (2) : 88 - 95
  • [4] Phosphorothioate oligodeoxynucleotides are potent platelet activators acting toll-like receptor 9 independently
    Flierl, U.
    Yao, J.
    Bassler, N.
    Peter, K.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 897 - 897
  • [5] Systemic toll-like receptor 9 agonist CpG oligodeoxynucleotides exacerbates aminoglycoside ototoxicity
    Yang, Chao-Hui
    Hwang, Chung-Feng
    Chuang, Jiin-Haur
    Lian, Wei-Shiung
    Wang, Feng-Sheng
    Yang, Ming-Yu
    HEARING RESEARCH, 2021, 411
  • [6] CpG oligodeoxynucleotides modulate the osteoclastogenic activity of osteoblasts via toll-like receptor 9
    Zou, W
    Amcheslavsky, A
    Bar-Shavit, Z
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (19) : 16732 - 16740
  • [7] Recognition of CpG oligodeoxynucleotides by human Toll-like receptor 9 and subsequent cytokine induction
    Suwarti, Suwarti
    Yamazaki, Tomohiko
    Svetlana, Chechetka
    Hanagata, Nobutaka
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2013, 430 (04) : 1234 - 1239
  • [8] Targeting Toll-like receptor 9 with CpG oligodeoxynucleotides enhances tumor response to fractionated radiotherapy
    Mason, KA
    Ariga, H
    Neal, R
    Valdecanas, D
    Hunter, N
    Krieg, AM
    Whisnant, JK
    Milas, L
    CLINICAL CANCER RESEARCH, 2005, 11 (01) : 361 - 369
  • [9] Molecular targeting of toll-like receptor 9 with CpG oligodeoxynucleotides (ODN) for enhancement of tumor radioresponse
    Mason, KA
    Neal, R
    Hunter, NR
    Ariga, H
    Whisnant, JK
    Krieg, AM
    Milas, L
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 60 (01): : S346 - S346
  • [10] Expression of Toll-like receptor 9 and response to bacterial CpG oligodeoxynucleotides in human intestinal epithelium
    Pedersen, G
    Andresen, L
    Matthiessen, MW
    Rask-Madsen, J
    Brynskov, J
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2005, 141 (02): : 298 - 306